These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 21658472)
21. Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes. Ito S; Ohtsuki S; Kamiie J; Nezu Y; Terasaki T J Neurochem; 2007 Dec; 103(6):2482-90. PubMed ID: 17908238 [TBL] [Abstract][Full Text] [Related]
22. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier. Papademetriou I; Vedula E; Charest J; Porter T PLoS One; 2018; 13(10):e0205158. PubMed ID: 30300391 [TBL] [Abstract][Full Text] [Related]
23. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Mourtas S; Lazar AN; Markoutsa E; Duyckaerts C; Antimisiaris SG Eur J Med Chem; 2014 Jun; 80():175-83. PubMed ID: 24780594 [TBL] [Abstract][Full Text] [Related]
24. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E. Neves AR; Queiroz JF; Weksler B; Romero IA; Couraud PO; Reis S Nanotechnology; 2015 Dec; 26(49):495103. PubMed ID: 26574295 [TBL] [Abstract][Full Text] [Related]
25. Attaching the phage display-selected GLA peptide to liposomes: factors influencing target binding. van Rooy I; Hennink WE; Storm G; Schiffelers RM; Mastrobattista E Eur J Pharm Sci; 2012 Feb; 45(3):330-5. PubMed ID: 22155541 [TBL] [Abstract][Full Text] [Related]
26. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells. Kuo YC; Chen HH J Drug Target; 2010 Jul; 18(6):447-56. PubMed ID: 20528098 [TBL] [Abstract][Full Text] [Related]
27. Uptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. Wagner S; Zensi A; Wien SL; Tschickardt SE; Maier W; Vogel T; Worek F; Pietrzik CU; Kreuter J; von Briesen H PLoS One; 2012; 7(3):e32568. PubMed ID: 22396775 [TBL] [Abstract][Full Text] [Related]
28. Enhanced cellular uptake and cytotoxicity studies of organometallic bioconjugates of the NLS peptide in Hep G2 cells. Noor F; Kinscherf R; Bonaterra GA; Walczak S; Wölfl S; Metzler-Nolte N Chembiochem; 2009 Feb; 10(3):493-502. PubMed ID: 19115329 [TBL] [Abstract][Full Text] [Related]
29. Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Qin Y; Chen H; Yuan W; Kuai R; Zhang Q; Xie F; Zhang L; Zhang Z; Liu J; He Q Int J Pharm; 2011 Oct; 419(1-2):85-95. PubMed ID: 21807083 [TBL] [Abstract][Full Text] [Related]
30. A new preparation strategy for surface modified PLA nanoparticles to enhance uptake by endothelial cells. Raudszus B; Mulac D; Langer K Int J Pharm; 2018 Jan; 536(1):211-221. PubMed ID: 29175342 [TBL] [Abstract][Full Text] [Related]
31. Solid lipid nanoparticles carrying chemotherapeutic drug across the blood-brain barrier through insulin receptor-mediated pathway. Kuo YC; Shih-Huang CY J Drug Target; 2013 Sep; 21(8):730-8. PubMed ID: 23815407 [TBL] [Abstract][Full Text] [Related]
32. Characteristics of manganese (Mn) transport in rat brain endothelial (RBE4) cells, an in vitro model of the blood-brain barrier. Fitsanakis VA; Piccola G; Aschner JL; Aschner M Neurotoxicology; 2006 Jan; 27(1):60-70. PubMed ID: 16169084 [TBL] [Abstract][Full Text] [Related]
33. Delivery of peptide and protein drugs over the blood-brain barrier. Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P; Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337 [TBL] [Abstract][Full Text] [Related]
34. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes. Johnsen KB; Moos T J Control Release; 2016 Jan; 222():32-46. PubMed ID: 26658072 [TBL] [Abstract][Full Text] [Related]
35. ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier. Dal Magro R; Ornaghi F; Cambianica I; Beretta S; Re F; Musicanti C; Rigolio R; Donzelli E; Canta A; Ballarini E; Cavaletti G; Gasco P; Sancini G J Control Release; 2017 Mar; 249():103-110. PubMed ID: 28153761 [TBL] [Abstract][Full Text] [Related]
36. Improving the transport of chemotherapeutic drugs across the blood-brain barrier. Orthmann A; Fichtner I; Zeisig R Expert Rev Clin Pharmacol; 2011 Jul; 4(4):477-90. PubMed ID: 22114857 [TBL] [Abstract][Full Text] [Related]
37. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis. Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340 [TBL] [Abstract][Full Text] [Related]
38. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. Hossen MN; Kajimoto K; Akita H; Hyodo M; Ishitsuka T; Harashima H J Control Release; 2010 Oct; 147(2):261-8. PubMed ID: 20647023 [TBL] [Abstract][Full Text] [Related]
39. Polyalkylcyanoacrylate nanoparticles for delivery of drugs across the blood-brain barrier. Andrieux K; Couvreur P Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(5):463-74. PubMed ID: 20049811 [TBL] [Abstract][Full Text] [Related]